CVS Health Corp (NYSE:CVS) shares traded 0.52% higher at $69.75 on Wall Street last session.
CVS stock price is now -7.38% away from the 50-day moving average and -4.11% away from the 200-day moving average. The market capitalization of the company currently stands at $87.78B.
With the price target of $78, Barclays recently initiated with Equal Weight rating for CVS Health Corp (NYSE: CVS). On February 26, 2024, Leerink Partners recently initiated its ‘Outperform’ rating on the stock quoting a target price of $88, while ‘HSBC Securities’ rates the stock as ‘Buy’
In other news, Shah Prem S, EVP and Pres-Pharm, Consumer W sold 29,473 shares of the company’s stock on Feb 16 ’24. The stock was sold for $2,267,947 at an average price of $76.95. Upon completion of the transaction, the EVP and Pres-Pharm, Consumer W now directly owns 39,765 shares in the company, valued at $2.77 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 03 ’23, Director LUDWIG EDWARD J bought 2,000 shares of the business’s stock. A total of $140,930 was incurred on buying the stock at an average price of $70.47. This leaves the insider owning 20,630 shares of the company worth $1.44 million. A total of 0.19% of the company’s stock is owned by insiders.
During the past 12 months, CVS Health Corp has had a low of $64.41 and a high of $83.25. As of last week, the company has a debt-to-equity ratio of 1.04, a current ratio of 0.86, and a quick ratio of 0.63.
The net profit margin was 2.33% and return on equity was 11.32% for CVS. The company reported revenue of $93.81 billion for the quarter, compared to $83.85 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 11.89 percent.
